Alethia Young insider trades

Open-market stock purchases and sales by Alethia Young, Director at Pacira BioSciences, Inc, from SEC Form 4 filings since Apr 1, 2022.

Recent trades

DateStockTradeValue
Jun 10, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Jun 10, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Jan 5, 2026BCYC Bicycle Therapeutics plcSold$15.8K
Jan 5, 2026BCYC Bicycle Therapeutics plcSold$12.3K
Jan 2, 2026BCYC Bicycle Therapeutics plcBought (not open market)—
Jan 2, 2026BCYC Bicycle Therapeutics plcSold$22.4K
Jan 2, 2026BCYC Bicycle Therapeutics plcBought (not open market)—
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—

Companies traded

  • PCRX Pacira BioSciences, Inc: other filings, last Jun 10, 2026
  • BCYC Bicycle Therapeutics plc: 8 sales, last Jan 5, 2026
  • PTCT PTC Therapeutics, Inc: 2 sales, last Jan 2, 2026
  • GRPH Graphite Bio, Inc: other filings, last Feb 21, 2023

Get free alerts when Alethia Young files a new trade →